DNA day on April 25th, celebrates major scientific achievements concerning DNA, in particular the completion of the Human Genome Project in 2003 and the discovery of DNA’s double helix…

As SARS-CoV-2 continues to mutate we demonstrate the performance of 

04/04/2022 Aptamer Group’s CEO, Dr Arron Tolley, has been awarded a Visiting Professorship in Biological and Translational Sciences from the Faculty of Health and Medical Sciences, University of Surrey, in…

14/10/2021 Selected as the preferred aptamer partner to support high-throughput development of affinity binding reagents for proteomics research  Contract comprises upfront payment and potential for…

Last week the government released their new Life Sciences Vision. This 10-year strategy for the sector aims to ensure that the United Kingdom builds a supportive environment for…

April 25th is DNA day. This day celebrates the completion of the Human Genome Project in 2003 and the discovery of DNA’s double helix in 1953. DNA aptamers are cheaper…

Anti-hapten antibodies are difficult and slow to generate limiting cheap and efficient bioanalysis in this field. Our proprietary methods offer standard assay formats, such as ELISA and lateral flow…

Novel biosensor diagnostics can improve patient outcomes and reduce healthcare costs. Download our application note to discover how our partner, QSM Diagnostics, is integrating Optimer technology into its rapid diagnostic…

Researchers at the National Cancer Institute (Centro di Referimento Oncologico IRCCS), Aviano, Italy, have published a new paper in Analytical and Bioanalytical Chemistry. Using aptamers from Aptamer…

A universal aptamer-based sensing strategy is proposed using DNA modified nanocarriers and Resistive Pulse Sensing (RPS) for the rapid (≤20 min) and label free detection of small molecules. The surface…